Literature DB >> 7648269

Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration.

S L Chang1, N A Patel, A A Romero.   

Abstract

The expression of the Fos proto-oncogene protein has been used as an anatomical marker of activated brain areas. Detection of Fos immunoreactivity can provide information about the sites of action of various stimuli at the level of single cell resolution. Following intraperitoneal injection of ethanol (16% w/v), Fos immunoreactivity was induced in several rat brain areas including the bed nucleus of the stria terminalis, paraventricular hypothalamic nucleus, the central nucleus of amygdala, Edinger-Westphal nucleus, locus coeruleus nucleus and parabrachial nucleus. The induction was dose dependent, and the length of activation time was different in each nucleus. Fos immunoreactivity in the supraoptic nucleus appeared only when a higher concentration of ethanol was injected. Repeated administration of ethanol twice daily for 17 or 24 days resulted in a desensitization of Fos immunoreactivity in these nuclei. These data suggest that induction of Fos immunoreactivity can be used to determine the sites at which ethanol acts on the brain, and may provide important information about the mechanisms underlying the tolerance and physical dependence of alcohol usage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648269     DOI: 10.1016/0006-8993(95)00210-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  55 in total

1.  Altered gene expression in the spleen of adolescent rats following high ethanol concentration binge drinking.

Authors:  Xiangqian Liu; Xin Mao; Sulie L Chang
Journal:  Int J Clin Exp Med       Date:  2011-10-11

2.  Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus.

Authors:  Irene Morganstern; Guo-Q Chang; Jessica R Barson; Zhiyu Ye; Olga Karatayev; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2010-03-10       Impact factor: 3.455

3.  Assessment of the aversive and rewarding effects of alcohol in Fischer and Lewis rats.

Authors:  Peter G Roma; Wesley W Flint; J Dee Higley; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2006-09-30       Impact factor: 4.530

Review 4.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

Review 5.  Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.

Authors:  Andrey E Ryabinin; Michael M Tsoory; Tamas Kozicz; Todd E Thiele; Adi Neufeld-Cohen; Alon Chen; Emily G Lowery-Gionta; William J Giardino; Simranjit Kaur
Journal:  Alcohol       Date:  2012-03-22       Impact factor: 2.405

6.  Latest trends in drugs of abuse - HIV infection and neuroAIDS.

Authors:  Sneham Tiwari; Madhavan Pn Nair; Shailendra K Saxena
Journal:  Future Virol       Date:  2013-02       Impact factor: 1.831

7.  Potential therapeutic strategy to treat substance abuse related disorders.

Authors:  Sulie L Chang
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

Review 8.  Ethanol effects on N-methyl-D-aspartate receptors in the bed nucleus of the stria terminalis.

Authors:  Tiffany A Wills; Danny G Winder
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

9.  Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking.

Authors:  Olivier George; Chelsea Sanders; John Freiling; Edward Grigoryan; Shayla Vu; Camryn D Allen; Elena Crawford; Chitra D Mandyam; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

Review 10.  Alcohol, stress hormones, and the prefrontal cortex: a proposed pathway to the dark side of addiction.

Authors:  Y-L Lu; H N Richardson
Journal:  Neuroscience       Date:  2014-07-03       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.